New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 19, 2009
06:31 EDTXNPT
theflyonthewall.com: XenoPort, Astellas announce submission of NDA in Japan
Astellas Pharma and XenoPort announced that a new drug application has been filed with the Pharmaceuticals and Medical Device Agency in Japan for ASP8825, also known as XP13512, as a potential treatment for restless legs syndrome. The data supporting safety and efficacy in the NDA filing comes from the successful Phase 2 study in RLS patients and long-term safety study conducted by Astellas in Japan and the RLS clinical program conducted by XenoPort in the United States. The acceptance of filing of the NDA triggers a $5 million milestone payment from Astellas to XenoPort. :theflyonthewall.com



News For XNPT From The Last 14 Days
Check below for free stories on XNPT the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
January 31, 2012
11:21 EDTXNPT
theflyonthewall.com: Piper Jaffray's biotech and specialty pharma analysts hold a conference call

Subscribe for More Information
:theflyonthewall.com